Loading
Head and Neck Cancer Studies / Oral Health in Cancer Treatment · Journal article
Health and Quality of Life Outcomes · August 17, 2026
Early or partial results. Treat as a signal, not a conclusion.
This prospective cohort study of 647 head and neck cancer patients found that those aged >75 years showed descriptively slower health utility recovery post-treatment compared to younger patients, but this age effect was attenuated and no longer statistically significant after adjustment for clinical stage, performance status, and treatment modality. The authors acknowledge selection bias and missing data, and note that larger, more detailed studies are needed to confirm whether age-independent factors drive the observed patterns.
Prospective longitudinal observational cohort study. Head and neck cancer patients; 647 included in longitudinal analytic cohort from 859 enrolled.. Intervention: Head and neck cancer treatment (surgery and/or radiation); stratified by age >75 years versus younger.. Compared with: Age >75 years versus younger age groups.. n = 647.
859 patients enrolled; 647 included in longitudinal analytic cohort Patients aged >75 years showed less complete recovery in mean HUS after early treatment-related decline in descriptive analyses Younger age groups had more positive average HUS slopes than patients aged >75 years in unadjusted primary mixed-effects model
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians should note that raw data suggest older patients may recover more slowly, but this appears driven by differences in clinical staging, performance status, and treatment choice rather than age alone. The attenuation after adjustment suggests careful geriatric assessment and individualized treatment planning may be more informative than age cutoff alone.
Observational longitudinal cohort study with descriptive findings that attenuate to non-significance after adjustment; exploratory subgroup analyses and acknowledged selection bias limit inference about age-related quality-of-life decline.
As stated by the source record.
Quoted from the source exactly as published.
Clinicians should note that raw data suggest older patients may recover more slowly, but this appears driven by differences in clinical staging, performance status, and treatment choice rather than age alone. The attenuation after adjustment suggests careful geriatric assessment and individualized treatment planning may be more informative than age cutoff alone.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Previous longitudinal evidence has suggested that patients aged > 75 years may be associated with a poorer Health Utility Index Mark 3 (HUI-3) trajectory. We compared the longitudinal health utility scores (HUS) of older (>75 years) versus younger patients with head and neck cancers across various clinical subgroups and identified factors associated with decline in quality of life. The study prospectively collected clinical information and follow-up data from head and neck cancer patients. The HUI-3 scale was used to assess changes in health-related quality of life at baseline, post-surgery, mid-radiation therapy, and at 3, 6, and 12 months. A linear mixed model was employed to evaluate the changes in HUS and age categories over time. We included 859 patients with head and neck cancer, of whom 647 were included in the longitudinal analytic cohort. In descriptive analyses, patients aged > 75 years showed less complete recovery in mean HUS after early treatment-related decline compared with younger patients. In the primary mixed-effects model, younger age groups had more positive average HUS slopes than patients aged > 75 years. However, these age-related differences were attenuated and were no longer statistically supported after adjustment for clinical stage, Eastern Cooperative Oncology Group (ECOG) performance status, and treatment modality. Subgroup findings were exploratory and were not consistently supported across all model-based comparisons. Patients aged > 75 years may be at risk for slower or incomplete post-treatment recovery in HUI-3–derived health utility. These findings should be interpreted cautiously given potential selection bias, missing data, and attenuation after covariate adjustment. Larger studies with detailed geriatric and domain-specific functional measures are needed to confirm these patterns.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.